We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$870M
AUM Growth
+$27M
Cap. Flow
+$16.7M
Cap. Flow %
1.92%
Top 10 Hldgs %
32.2%
Holding
103
New
12
Increased
47
Reduced
28
Closed
15

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$16.5M
2
WGS icon
GeneDx Holdings
WGS
+$13.7M
3
DHR icon
Danaher
DHR
+$9.08M
4
DXCM icon
DexCom
DXCM
+$7.49M
5
ASND icon
Ascendis Pharma A/S
ASND
+$6.86M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$27.6M
2
UNH icon
UnitedHealth
UNH
+$26.3M
3
SYK icon
Stryker
SYK
+$10.2M
4
GILD icon
Gilead Sciences
GILD
+$9.29M
5
PODD icon
Insulet
PODD
+$7.14M

Sector Composition

Rank Sector Weight
1 Healthcare 99.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLN
101
Silence Therapeutics
SLN
$641M
– –
-401,746
Closed -$1.13M
UNH icon
102
UnitedHealth
UNH
$364B
– –
-50,213
Closed -$26.3M
YARW
103
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
– –
-4,360
Closed -$344K
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Parkman Healthcare Partners held 103 positions worth $870M, up 3.2% from $843M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parkman Healthcare Partners's Q2 2025 filing shows 12 new, 47 increased, 28 reduced and 15 closed positions. Its largest new stake was IQVIA: 109,500 shares worth $17.3M. The largest sale was Becton Dickinson, an estimated $27.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

  • Parkman Healthcare Partners's largest Q2 2025 buy was IQVIA: 109,500 shares worth $17.3M.
  • Parkman Healthcare Partners added most to Danaher in Q2 2025, an estimated $9.08M increase.
  • Parkman Healthcare Partners's biggest Q2 2025 reduction was Stryker, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Becton Dickinson in Q2 2025, selling an estimated $27.6M.
  • Parkman Healthcare Partners's ten largest holdings make up 32% of its $870M portfolio in Q2 2025.
  • Parkman Healthcare Partners opened 12 new positions and closed 15 in Q2 2025.
  • Parkman Healthcare Partners's portfolio value rose 3.2% quarter-over-quarter to $870M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.